Enovis (ENOV) Stock Looks Undervalued Based On Future Cash Flow

Enovis has seen its share price fall sharply in recent years, which raises a very specific question for anyone looking at the stock today. Are the cash flows that the business can generate over time enough to justify where the market is currently pricing it?

• Over the past 5 years the share price has fallen 79.7%. This puts the focus squarely on whether the underlying cash flow story has changed as much as the stock chart.
• Recent sales growth and management’s confidence in future performance may support expectations for stronger cash generation, especially if margin improvements and free cash flow progress continue.
• Prefer to judge Enovis on sales? See what Enovis's 0.4x P/S says about the price.

The issue now is whether Enovis’s current market value lines up with what a Discounted Cash Flow (DCF) view of its future cash flows would suggest.

If you are weighing Enovis through the lens of its cash flows and recent share price decline, it can help to compare that setup with other businesses screened for 30 high quality undervalued stocks

Is Enovis a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model here values Enovis based on the cash it is expected to generate for shareholders over time. Latest twelve month free cash flow sits at about $79.7 million, with the model assuming that future free cash flow gradually grows into the $120 million to $160 million range over the coming decade rather than exploding higher or collapsing.

Those projections, when discounted back, put Enovis' estimated intrinsic value substantially above the current share price of $17.69. Because management recently reaffirmed its 2026 guidance and highlighted improving free cash flow, the gap suggested by the DCF model can partly reflect investors staying cautious despite that message. For anyone tracking Enovis, the key question is whether that disconnect between cash flow estimates and the trading price eventually closes or persists. Find out what Enovis could be worth using our Discounted Cash Flow (DCF) estimate.

The Enovis Narrative: What Would Justify Today's Price?

Narratives for Enovis pick up where the DCF puzzle leaves off and spell out which combinations of growth, profitability and earnings paths would need to play out for the share price to look meaningfully higher or lower than today. Each one ties its number to a concrete view on how Enovis' expansion, margins and risk profile could evolve, giving you a reference point you can revisit as fresh results and guidance come through on Simply Wall St's Community page.

One of the top community narratives on Enovis: 66% undervalued

"Portfolio shaping actions such as the divestiture of Dr. Comfort, combined with SKU rationalization and EGX driven productivity programs, are concentrating resources..."

Discover why this Narrative puts Enovis at 66% undervalued.

One more angle on Enovis that could change the story

Before you decide how Enovis fits in your watchlist, it is worth checking who is actually steering the business and how their rewards line up with your interests. See who runs Enovis and how they are paid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com